GlaxoSmithKline PLC (NYSE:GSK)

44.26
Delayed Data
As of Nov 11
 -0.16 / -0.36%
Today’s Change
36.41
Today|||52-Week Range
46.01
+15.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues36.5B37.5B38.9B41.1B
 
 
 
 
 
Cost of Goods Sold11.1B10.3B10.5B10.7B
 
 
 
 
 
Depreciation And Amortization2.5B2.4B2.5B2.5B
 
 
 
 
 
 
Operating ExpensesGross Income22.9B24.8B25.9B27.9B
 
 
 
 
 
General Expenses16.1B15.6B15.6B17.2B
 
 
 
 
 
Research And Development5.2B4.7B5.0B4.9B
 
 
 
 
 
Total Operating Expenses29.7B28.3B28.6B30.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.8B9.2B10.3B10.7B
 
 
 
 
 
Extraordinary Credit47.3M191.1M----
 
 
 
Extraordinary Charge-7.2B-7.1B-5.5B-4.0B
 
 
 
 
 
Interest Expense On Debt1.0B923.2M898.9M942.7M
 
 
 
 
 
Equity In Earnings21.4M6.7M16.7M41.3M
 
 
 
 
 
Other Expenses17.3B1.2B600.1M509.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income16.0B2.6B4.5B6.4B
 
 
 
 
 
Income Taxes-3.3B-1.2B-1.7B-1.0B
 
 
 
 
 
Minority Interest-76.3M-201.9M-820.3M-564.0M
 
 
 
 
 
Net Income12.8B1.2B2.0B4.8B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.4B2.4B2.4B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.4B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$5.32$0.51$0.81$1.97
 
 
 
 
 
EPS Diluted$5.26$0.50$0.80$1.94